Are you Dr. Dillon?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 25 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
# Bwh
Boston, MA 02115Phone+1 617-732-7510
Summary
- Dr. Deborah Dillon, MD is a board certified pathologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts and Connecticut. She is affiliated with Brigham and Women's Hospital and is an Assistant Professor of Pathology at Brigham and Women's Hospital.
Education & Training
- Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 1992 - 1995
- Yale School of MedicineClass of 1992
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- MA State Medical License 2004 - 2026
- CT State Medical License 1997 - 2004
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Molecular Genetic Pathology
Publications & Presentations
PubMed
- T Cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL1 and TNFα Inflammation.Nam Woo Cho, Sophia M Guldberg, Barzin Y Nabet, Jie Zeng Yu, Eun Ji Kim
Cancer Immunology Research. 2025-02-03 - 1 citationsAnalysis of HER2 expression changes from breast primary to brain metastases and the impact of HER2-low expression on overall survival.Alyssa M Pereslete, Melissa E Hughes, Alyssa R Martin, Janet Files, Kyleen Nguyen
Neuro-Oncology. 2025-01-12 - 12 citationsA pathology foundation model for cancer diagnosis and prognosis prediction.Xiyue Wang, Junhan Zhao, Eliana Marostica, Wei Yuan, Jietian Jin
Nature. 2024-10-01
Press Mentions
- New Agent Overcomes Drug Resistance in HER2-Positive Breast Cancer, Preclinical Study ShowsMarch 14th, 2016